Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

810 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed Melanomas.
Rebecca VW, Xiao M, Kossenkov A, Godok T, Brown GS, Fingerman D, Alicea GM, Wei M, Ji H, Bravo J, Chen Y, Fane ME, Villanueva J, Nathanson K, Liu Q, Gopal YNV, Davies MA, Herlyn M. Rebecca VW, et al. Among authors: villanueva j. bioRxiv [Preprint]. 2023 Jan 21:2023.01.20.524923. doi: 10.1101/2023.01.20.524923. bioRxiv. 2023. PMID: 36711814 Free PMC article. Preprint.
Melanoma and the tumor microenvironment.
Villanueva J, Herlyn M. Villanueva J, et al. Curr Oncol Rep. 2008 Sep;10(5):439-46. doi: 10.1007/s11912-008-0067-y. Curr Oncol Rep. 2008. PMID: 18706274 Free PMC article. Review.
CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations.
Smalley KS, Xiao M, Villanueva J, Nguyen TK, Flaherty KT, Letrero R, Van Belle P, Elder DE, Wang Y, Nathanson KL, Herlyn M. Smalley KS, et al. Among authors: villanueva j. Oncogene. 2009 Jan 8;28(1):85-94. doi: 10.1038/onc.2008.362. Epub 2008 Sep 15. Oncogene. 2009. PMID: 18794803 Free PMC article.
Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K.
Villanueva J, Vultur A, Lee JT, Somasundaram R, Fukunaga-Kalabis M, Cipolla AK, Wubbenhorst B, Xu X, Gimotty PA, Kee D, Santiago-Walker AE, Letrero R, D'Andrea K, Pushparajan A, Hayden JE, Brown KD, Laquerre S, McArthur GA, Sosman JA, Nathanson KL, Herlyn M. Villanueva J, et al. Cancer Cell. 2010 Dec 14;18(6):683-95. doi: 10.1016/j.ccr.2010.11.023. Cancer Cell. 2010. PMID: 21156289 Free PMC article.
Will engineered T cells expressing CD20 scFv eradicate Melanoma?
Somasundaram R, Villanueva J, Herlyn M. Somasundaram R, et al. Among authors: villanueva j. Mol Ther. 2011 Apr;19(4):638-40. doi: 10.1038/mt.2011.46. Mol Ther. 2011. PMID: 21455210 Free PMC article. No abstract available.
Sorting through the many opportunities for melanoma therapy.
Herlyn M, Villanueva J. Herlyn M, et al. Among authors: villanueva j. Pigment Cell Melanoma Res. 2011 Oct;24(5):975-7. doi: 10.1111/j.1755-148X.2011.00906.x. Pigment Cell Melanoma Res. 2011. PMID: 21899726 No abstract available.
810 results